$3.83
-0.17-4.25%
At Close: -
$3.70
-0.13-3.39%
After Hours: 5:13 PM EDT
15 minutes delayed
Comments
Loading...
Macrogenics (NASDAQ:MGNX) Stock Quotes, Forecast and News Summary
Macrogenics Stock (NASDAQ: MGNX) stock price, news, charts, stock research, profile.
| Open | $3.80 |
| Close | $3.83 |
| Volume / Avg. | 1.41M / 2.46M |
| Day Range | $3.62 - $3.91 |
| 52 Wk Range | 3.14 - 21.88 |
| Market Cap | $231.74M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 34 |
| Short Interest | 15.17% |
| Days to Cover | 9.16 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Macrogenics Inc
Sector
Health Care
Industry
Biotechnology
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based ther...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Macrogenics (MGNX) stock?
You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.
Who are Macrogenics (MGNX) competitors?
Other companies in Macrogenics’s space includes: Molecular Partners (NASDAQ:MOLN), Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), Zentalis Pharma (NASDAQ:ZNTL) and Inovio Pharmaceuticals (NASDAQ:INO).
What is the target price for Macrogenics (MGNX) stock?
There is no analysis for Macrogenics.
What is the forecast for Macrogenics (MGNX) stock?
Macrogenics has a consensus price target of $13.27.
Current stock price for Macrogenics (MGNX)?
The stock price for Macrogenics (NASDAQ: MGNX) is $3.7 last updated August 2, 2024 at 5:13 PM EDT.
Does Macrogenics (MGNX) pay a dividend?
There are no upcoming dividends for Macrogenics.
When is Macrogenics (NASDAQ:MGNX) reporting earnings?
Macrogenics’s Q2 earnings are confirmed for Friday, August 16, 2024.
Is Macrogenics (MGNX) going to split?
There is no upcoming split for Macrogenics.
What sector and industry does Macrogenics (MGNX) operate in?
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.